News
February, 2019
First long-term study (FH02) from University of Manchester confirming effectiveness of annual screening mammography from age 35-39 for women at moderate or high risk of developing breast cancer. 80% of invasive cancers detected were less than 2cm, and 80% had not spread to lymph nodes. We will be updating our risk stratified breast screening protocol at Check4Cancer in light of these data
December, 2018
The PREDICT breast cancer survival and treatment prediction model won the People's Choice Award at the Office for National Statistics (ONS) Research Excellence Awards on 22 November 2018.
June, 2018
Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast cancer diagnosis pathway to the Association of Breast Surgery annual conference in Birmingham today.
June, 2018
Check4Cancer is delighted to announce it has been awarded ‘Diagnostics provider of the year’ at the 2018 Health Investor Awards held at the Grosvenor Hotel, London.
Read more: Check4Cancer wins Diagnostics Provider of the Year at the 2018 Health Investor Awards
June, 2018
NHS breast screening error affects 450,000 women
In May 2018, Health Secretary Jeremy Hunt announced to the House of Commons that a computer error had resulted in a failure to invite 450,000 women aged 68-71 in England for a screening mammogram, and that this had shortened the lives of as many as 270 women. A helpline has been set up (0800 169 2692), and the plan is to offer these women a screening mammogram within the next six months. Affected women who are concerned about recent changes in their breasts have been directed to their GP for advice and referral to a diagnostic breast clinic if necessary.
May, 2018
Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.
Read more: Check4Cancer appoints Louise Mills as Clinical Services Director
May, 2018
Private providers of screening mammograms such as BreastHealth UK (www.breasthealthuk.com) are expecting a surge in requests from women who do not want to wait up to 6 months for their mammogram.
Read more: Private providers expect surge in mammogram requests
February, 2018
Check4Cancer is delighted to announce that audit data from both our OneStop breast diagnostic services (through BreastHealth UK) and our genetics testing pathways (through GeneHealth UK) has been selected for presentation at the 2018 Association of Breast Surgery Annual Conference.
Proud that this reflects the excellent quality of everything we do as a company.
For more information on this year's event see: Association of Breast Surgery Annual Conference 2018
February, 2018
By working closely with large corporate clients and UK private medical insurance companies, Check4Cancer has been able to modernise the delivery of private cancer diagnostic services to suit the changing private and corporate markets, while improving patient-focused outcomes related to their clinical care.
Could this be our year? Check4Cancer has been shortlisted as one of four finalists in the category 'Diagnostics provider of the year' at the Healthcare Investor Awards 2018.
The 2018 Health Investor Awards will be presented on 13th June in London.
November, 2017
Cambridge Magazine features Professor Gordon Wishart and the Check4Cancer team talking about MyBreastRisk, the first DNA saliva test that predicts a woman's personal breast cancer risk.
October, 2017
BreastHealth UK launches MyBreastRisk - the first commercially available test that combines both genetic and lifestyle factors to determine a woman’s personal lifetime breast cancer risk.
March, 2017
Check4Cancer and Cigna have been working together for the past 14 months to tackle early detection of breast cancer and skin cancer.
Cigna teamed up with BreastHealth UK, in January 2016 to provide OneStop breast cancer diagnostics and with SkinHealth UK in June 2016 to offer customers rapid access to skin cancer specialists across the UK.
BreastHealth UK and SkinHealth UK are part of Check4Cancer Ltd.
We are proud to announce that for the second year running Check4Cancer and Cigna UK have been shortlisted for ‘Diagnostics care provider of the year’. For more information please see: Health Investor Awards 2017.
March, 2017
Association of Breast Surgery Conference, 15th & 16th May 2017, Belfast Waterfront
Read more: BreastHealth UK exhibiting at ABS Conference in Belfast
July, 2016
A major new study – the largest of its kind ever undertaken – has been hailed as a milestone in the understanding of breast cancer and its causes.
The new study, published in Nature, provides a “near-perfect picture” of the genetic processes that lead to breast cancer and opens up new possibilities for treatment and prevention of the disease.
Read more: “Milestone” breast cancer study paves way to new treatments
May, 2016
Gordon Wishart, Professor of Cancer Surgery and Chief Medical Officer of Check4Cancer has called for self-examination to be a priority amongst women as part of the fight against breast cancer.
“Women themselves are the first line of defence when it comes to breast health,” he says, “not only by moderating lifestyle factors that affect their risk but because they are best placed to detect unusual changes in their own bodies. So often cancer makes us feel that we are not in control of our health, but self-checking gives some of that sense of control back. More importantly, it also saves lives: around 90% of breast lumps are found by women themselves.”
April, 2016
New figures released by Cancer Research UK have shown a 12% increase in the rate of cancer since the mid-90s.
More than 352,000 people are now diagnosed with cancer in the UK each year, compared with more than 253,000 people getting the disease every year two decades before (a rise from 540 per 100,000 people in 1993-1995 to 603 per 100,000 in 2011-2013).
February, 2016
2015 proved a turbulent year for national and international politics – but the news that dominated the New Year was cancer, with musicians Lemmy and David Bowie and actor Alan Rickman all dying of the disease within days of each other.
“These deaths occurring so close together were widely regarded as a tragic coincidence,” says Gordon Wishart, Professor of Cancer Surgery and Medical Director of BreastHealth UK (part of Check4Cancer group of companies). “Unfortunately they are indicative of general trends, and we are likely to see this more often. Celebrity cases can help focus attention on efforts to combat the disease, but the important message we need to get across is that cancer affects us all. One in two people born after 1960 will be diagnosed with some form of cancer during their lifetime, so if it is not us, it will be someone we know.”
Read more: Cancer detection and prevention: a message for World Cancer Day, 4 February 2016
November, 2015
Sales of bacon and sausages fell by £3m in UK supermarkets in just two weeks following the World Health Organization’s announcement that processed meats are “definite” carcinogens.
The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, placed processed meats in the same category as smoking, asbestos and plutonium. But, shocking as that sounds, it does not mean that the risk of cancer is elevated to the same level by all these substances or processes.
Read more: The list of 116 things that cause cancer – and how to use it
October, 2015
A research team from the Wellcome Trust Sanger Institute in Cambridge has found a clue as to why some breast cancers relapse – a discovery that could be the key to more effective treatment.
About one in five people with breast cancer suffer a relapse, with the cancer returning either in the same place as the original tumour or in another part of the body.
Read more: Cambridge scientists discover genetic clue to breast cancer relapse
Fill out your details and one of our friendly staff will call you back to book your appointment with a breast specialist.
If you are worried you may have breast cancer
Discover your personal breast cancer risk
If you want a private or supplementary mammogram
